Latigo Biotherapeutics (LTGO) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
First Tracks Biotherapeutics is the larger company by market cap ($1.10 billion vs $992.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LTGO | TRAX |
|---|---|---|
| Share price | $14.98 | $30.83 |
| Market cap | $992.83M | $1.10B |
| 1-day change | -3.51% | +0.78% |
| EPS (TTM) | $-2.52 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.93 | $49.91 |
| 52-week low | $14.89 | $14.72 |
| Distance from 52-week high | -42.25% | -38.23% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +248.91% | +127.05% |
| Average volume | 394.20K | 785.86K |
| Shares outstanding | 66.30M | 35.73M |
| Employees | 66 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Latigo Biotherapeutics
LTGO stock →Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
LTGO vs TRAX FAQ
Which is bigger, Latigo Biotherapeutics or First Tracks Biotherapeutics?
First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.10B compared with $992.83M for Latigo Biotherapeutics (LTGO).
Are Latigo Biotherapeutics and First Tracks Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.